Single Stock Loan for SGD30m For A Singaporean High-Net-Worth Individual Single Stock Loan For SGD30m For A Singaporean High-Net-Worth Individual Case Overview: Client Location: Singapore Ultimate Beneficial Owner (UBO): Wealthy investor Loan Amount: SGD 30,000,000 Loan-to-Value (LTV): 55% Share Type: Shares listed on the Singapore Exchange (SGX) Interest Rate: 4.5% per annum Context and Purpose: In Singapore, where sophisticated investors strategically optimize their portfolios, single stock loans become pivotal tools for creating liquidity, exploring new ventures, or acquiring assets. Our client, a high-net-worth individual prominent in Singapore's finance sector, sought a SGD 30 million loan against shares listed on theRead more →
Single Stock Loan for HKD800m For A Hong Kong High-Net-Worth Individual Single Stock Loan for HKD800m For A Hong Kong High-Net-Worth Individual Stock loans in Hong Kong offer an effective way for shareholders to leverage their equity in publicly traded companies without having to sell their shares. By using their stock as collateral, borrowers can access substantial funds while still retaining ownership of their shares. These loans are typically non-recourse, meaning that in the event of default, the lender can only seize the pledged stocks and cannot pursue other assets, which minimizes risk for the borrower. In Hong Kong’s dynamicRead more →
Single Stock Loan for NZD20m For New Zealand High-Net-Worth Individual Single Stock Loan for NZD20m For New Zealand High-Net-Worth Individual Case Overview: Client Location: New Zealand Ultimate Beneficial Owner (UBO): Wealthy individual Loan Amount: NZD 20,000,000 Loan-to-Value (LTV): 55% Share Type: Shares listed on the New Zealand Stock Exchange (NZX) Interest Rate: 4.50% per annum Context and Purpose: In New Zealand, affluent individuals often explore sophisticated financial strategies to optimize their wealth. Single stock portfolios can be instrumental in creating liquidity, pursuing new investments, or acquiring assets. In this case, a high-net-worth individual from New Zealand, a prominent figure inRead more →
Single Stock Loan Of AUD15m for Australian High-Net-Worth Individual Single Stock Loan Of AUD15m for Australian High-Net-Worth Individual Case Overview: Client Location: Australia Ultimate Beneficial Owner (UBO): High-net-worth individual Loan Amount: AUD 15,000,000 Loan-to-Value (LTV): 60% Share Type: Shares listed on the Australian Securities Exchange (ASX) Interest Rate: 5.2% per annum Context and Purpose: High-net-worth individuals in Australia often explore financial strategies to optimize their portfolios. Single stock portfolios are utilized to create liquidity, invest in new opportunities, or acquire assets. In this case, an Australian client, a successful entrepreneur in the manufacturing energy sector, sought a AUD 15 millionRead more →
Single Stock Loan for USA Based Client Looking to Purchase A New Company Single Stock Loan for USA Based Client Looking to Purchase A New Company Case Overview: Client Location: United States High-net-worth individual Loan Amount: USD250,000,000 Loan-to-Value (LTV): 55% Share Type: Shares listed on the New York Stock Exchange Interest Rate: 5.80% per annum Context and Purpose: Single stock portfolios, often considered high risk, are not uncommon among high-net-worth individuals. Such portfolios can be leveraged to create liquidity, make strategic acquisitions, or invest in real estate. In this case, the client, an owner of a US publicly listed companyRead more →
Case Study: Wealthy Spain Investor Requires EUR7m Stock Loan for philanthropic initiatives and medical research Wealthy Spain Investor Requires EUR7m Stock Loan for Philanthropic Initiatives and Medical Research Client Profile: Wealthy philanthropist based in Spain required a EUR7m stock loan for medical research. Financial Position: Extensive ownership in a Spanish pharmaceutical company. Financing Requirement: €7 million for philanthropic initiatives and medical research. Client's Objective: Access liquidity for charitable projects while safeguarding ownership in the pharmaceutical company for future societal impact. Case Study: Wealthy Spain Investor Requires EUR7m Stock Loan for philanthropic initiatives and medical research Client's Objective: Driven by aRead more →


